Mira Pharmaceuticals earnings were -$31.4M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest MIRA earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$1.2M, down 108% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MIRA reported annual earnings of -$32.0M, with 307.5% growth.
Mira Pharmaceuticals Earnings Reports & History FAQ
What were Mira Pharmaceuticals's earnings last quarter?
Mira Pharmaceuticals (NASDAQ: MIRA) reported Q1 2026 earnings per share (EPS) of -$0.03, up 72.73% year over year. Total MIRA earnings for the quarter were -$1.15 million. In the same quarter last year, Mira Pharmaceuticals's earnings per share (EPS) was -$0.11.
Is Mira Pharmaceuticals profitable or losing money?
As of the last Mira Pharmaceuticals earnings report, Mira Pharmaceuticals is currently losing money. Mira Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$9.81 million, a 134.93% increase year over year.
What was MIRA's earnings growth in the past year?
As of Mira Pharmaceuticals's earnings date in Q2 2026, Mira Pharmaceuticals's earnings has grown year over year. MIRA earnings in the past year totalled -$31.37 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.